Targeting the Brain’s Own Opioid System to Improve Mental Health
Millions of people worldwide suffer from the emotional and behavioral symptoms of serious mental illness such as compulsivity, self-injury and addiction.
Epiodyne is developing new medicines based on emerging understanding of the role of endorphins in health and disease.
Based on Nobel Prize winning research, we are combining modern drug discovery techniques with exciting neuroscience insights to develop novel medicines for a range of brain disorders.
Millions of people worldwide suffer from the emotional and behavioral symptoms of serious mental illness such as compulsivity, self-injury and addiction.
At Epiodyne, we believe we can alleviate this growing burden by tapping into the brain’s endogenous opioid system. Our approach harnesses the power of the body’s endorphin signaling pathways to relieve behavioral symptoms of brain disorders.